Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

Edwards to sell LifeStent products to C. R. Bard for up to $140 million

Dec. 10, 2007

By Amanda Pedersen

Pelikan draws in $69M for blood glucose monitoring

Dec. 7, 2007

By Amanda Pedersen

Study fuels debate over CT benefits versus cancer risk

Dec. 6, 2007

By Amanda Pedersen

Bruker BioSciences to acquire Bruker BioSpin for $914 million

Dec. 6, 2007

By Amanda Pedersen

Oracle to merge with Precision; Digilab buys Genomic Solutions

Dec. 5, 2007

By Amanda Pedersen

Bruker BioSciences to acquire Bruker BioSpin for $914 million

Dec. 4, 2007

By Amanda Pedersen

Study fuels debate over CT benefits vs. risk of cancer

Dec. 3, 2007

By Amanda Pedersen

Cardinal to customize procedure kits for 11,500 hospitals/centers

Nov. 30, 2007

By Amanda Pedersen

UCLA study validates use of 'dynamic' positions for MRI

Nov. 29, 2007

By Amanda Pedersen

UCLA study validates use of 'dynamic' positions for MRI

Nov. 26, 2007

By Amanda Pedersen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...